leadf
logo-loader
AIM:DDDD NASDAQ:LBPS

4D pharma PLC

Receive alerts
Market:
AIM
Market Cap:
£124.41 m
Price
69.00 GBX
Change
5.34%
52 weeks high
183.00
52 weeks low
63.00

In brief

Founded in February 2014, 4D pharma is a world leader in the development of Live Biotherapeutics, a novel and emerging class of drugs, defined by the FDA as biological products that contain a live organism, such as a bacterium, that is applicable to the prevention, treatment or cure of a disease. 

The company has developed a proprietary platform, MicroRx®, that rationally identifies Live Biotherapeutics based on a deep understanding of function and mechanism.

Snapshot

Working in the emerging area of the human microbiome, the company has developed candidates in cancer, gastrointestinal and respiratory ailments, and autoimmune disease